August wasn't a great month for the Cochlear (ASX:COH) share price

How did shares in the hearing implant manufacturer perform in August?

| More on:
A woman leans forward with her hand behind her ear, as if trying to hear information.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Despite a stellar year thus far, August has not been kind to the Cochlear Limited (ASX: COH) share price.

Shares in the hearing implant manufacturer closed nearly 6% lower for the month, swapping hands for $233.20 at the end of trading yesterday.

Many investors were quick to dump their shares in Cochlear after the company released its full-year results for FY21.

Let's take a look at what happened with the Cochlear share price in August.

Cochlear share price tanks on FY21 results

Much of the decline in Cochlear's share price in August can be attributed to the company's results for FY21.

Despite meeting guidance and delivering a dividend boost, investors were quick to sell their shares in the company.

Highlights from Cochlear's full-year report for FY21 included;

  • Cochlear implant units up 15% to 36,456
  • Sales revenue up 10% to $1,493.3 million
  • Underlying net profit up 54% to $236.7 million
  • Net profit margin expanded from 11% to 16%
  • Underlying earnings per share (EPS) up 40% to $3.60
  • Full year dividend up 59% to $2.55
  • FY 2022 guidance: Net profit growth of 12% to 20%

Cochlear noted that a successful rollout of COVID-19 vaccines will see elective surgeries return to their pre-pandemic levels. 

Why were shares in Cochlear sold-down?

Although Cochlear met many of its key metrics, the company performed below market expectations.

The company had previously set an underlying net profit guidance for FY21 of between $225 million and $245 million.

However, analysts were expecting the company to hit the top-end of its guidance and anticipated a return to normal growth in FY22-23.

The dour outlook on Cochlear's share price was reflected in a recent note from leading broker Citi.

Analysts from the broker retained a sell rating on the company with a share price target of $220.00.

According to the note, analysts expect lower margins and cautioned that Cochlear's sales may take longer to normalise.

Snapshot of the Cochlear share price

Despite a disappointing performance in August, the Cochlear share price has had a stellar year thus far.

Shares in the hearing implant company have soared more than 22.5% since the start of 2021.

Prior to releasing its full-year report for FY21, the Cochlear share price was up more than 35% for the year and trading at record highs.

Motley Fool contributor Nikhil Gangaram has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended Cochlear Ltd. The Motley Fool Australia has recommended Cochlear Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Fallers

A young man clasps his hand to his head with his eyes closed and a pained expression on his face as he clasps a laptop computer in front of him, seemingly learning of bad news or a poor investment.
Share Fallers

Why Burgundy Diamond Mines, Clarity Pharmaceuticals, EML, and Zip are sinking today

These ASX shares are ending the week in the red. But why?

Read more »

A worried man holds his head and look at his computer.
Share Fallers

Why 29Metals, Brainchip, Platinum, and Premier Investments shares are falling today

These ASX shares are having a tough time on hump day.

Read more »

Man with his head in his head because of falling share price.
Share Fallers

Why 29Metals, Atlas Arteria, IDP Education, and Mineral Resources shares are falling

These ASX shares are having a tough time on Tuesday. But why?

Read more »

A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
Share Fallers

Why ALS, EOS, NRW, and Patriot Battery Metals are dropping today

These ASX shares are starting the week in the red.

Read more »

A man looking at his laptop and thinking.
Technology Shares

Why are these ASX tech shares getting smashed today?

Owners of these two stocks are missing out today.

Read more »

a man weraing a suit sits nervously at his laptop computer biting into his clenched hand with nerves, and perhaps fear.
Share Fallers

Why AGL, Brickworks, IGO, and New Hope shares are dropping today

These ASX shares are having a poor session. But why?

Read more »

Frustrated stock trader screaming while looking at mobile phone, symbolising a falling share price.
Share Fallers

Why Amcor, Arafura, Brainchip, and South32 shares are tumbling today

These ASX shares are having a tough time on hump day. But why?

Read more »

A young woman holds an open book over her head with a round mouthed expression as if to say oops as she looks at her computer screen in a home office setting with a plant on the desk and shelves of books in the background.
Share Fallers

Why Aussie Broadband, Liontown, Metals Acquisition, and Seek shares are falling

These ASX shares are having a poor session. But why?

Read more »